Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytyc Corp.
Company announces arbitration panel decision in royalty dispute with DEKA
April 17th, 2005
Cytyc Corp. (CYTC), a women's health company, announced that an arbitration panel issued a partial final award regarding the payment of royalties pursuant to a 1993 licensing agreement relating to its ThinPrep Pap Test products. This partial final award established the products upon which a royalty of 1% is due, but reserved decision on the exact amount of the final award of past royalties until both parties have submitted royalty calculations to the panel. In a dispute with DEKA Products, Ltd., Partnership (DEKA), which was subject to binding arbitration, Cytyc contended that the terms of the license required payment of a 1% royalty only on the...
Source: Women's Health Law Weekly (2005-04-17)
|
